Portal de investigación
Evaluación del resistoma intestinal de pacientes con espondilo artritis y su relación con microbioma y marcadores de inflamación
Datos básicos
- Código:
- Dotación:
- Año incial:
- 2023
- Año final:
- 2024
Objetivos del proyecto
Determinar el resistoma a partir de muestras de materia fecal de pacientes con Espondilartitis por secuenciación de nueva generación y establecer los genes de resistencia Determinar el resistoma a partir de muestras de materia fecal de pacientes con Espondiloartritis y controles y establecer asociación con niveles de IgA secretora, Proteína C reactiva y actividad de la enfermedad.
Documentos
- No hay documentos
Participantes
Unidades de investigación
Outputs del proyecto
Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study;
Parra-Izquierdo V; (...); Flórez-Sarmiento C
Article. 10.1016/j.gastrohep.2023.10.003. 2023
Colonoscopy aspiration lavages for mucosal metataxonomic profiling of spondylarthritis-associated gastrointestinal tract alterations
Marquez-Ortiz RA; (...); Romero-Sanchez C
Article. 10.1038/s41598-023-33597-y. 2023
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity
Calixto O.-J.; (...); Bello-Gualtero JM
Article. 10.1177/09612033231186718. 2023
Differences in the distribution of hemoglobin variants according to the geographic regions in a Colombian population
Vargas-Hernández DA; (...); Romero-Sánchez C
Article. 10.1016/j.htct.2022.11.012. 2023
Differential gut microbiome in spondyloarthritis patients associated to Blastocystis colonization
Nieto-Clavijo C; (...); Chaparro-Olaya J
Article. 10.1038/s41598-023-39055-z. 2023
Evaluation of Quality of Life in Health by IMPACT-III in Colombian Pediatric Patients With Inflammatory Bowel Disease
Parra-Izquierdo, V; (...); Serrano, M
Meeting Abstract. 10.14309/01.ajg.0000996084.75247.15. 2023
Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis
Castellar-Mendoza C; (...); Romero-Sánchez C
Article. 10.1007/s00784-023-04964-w. 2023
Posttranslational modifications in psoriatic arthritis: A systematic literature review
Calixto O.-J.; (...); Perdomo S.J.
Review. 10.1016/j.autrev.2023.103393. 2023
Real-Life Experience of Tofacitinib in Colombian Patients With Severe Acute Ulcerative Colitis: An Observational Study
Parra-Izquierdo, V; (...); Florez-Sarmiento, C
Meeting Abstract. 10.14309/01.ajg.0000996096.51681.ac. 2023
Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic
Beltrán EO; (...); Castellanos JE
Article. 10.3389/fpubh.2023.1225037. 2023
THE FECAL MICROBIOME AND THE LIPID PROFILE OF PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPLEX RELATIONSHIP WITH PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS
Pulido-Daza, S; (...); Romero-Sanchez, C
Meeting Abstract. 2023
The Interaction Effect of Anti-RgpA and Anti-PPAD Antibody Titers: An Indicator for Rheumatoid Arthritis Diagnosis
Castillo DM; (...); Castellanos JE
Article. 10.3390/jcm12083027. 2023
Use of Tofacitinib as an Alternative in Moderately Severe Ulcerative Colitis in Pediatric Patients Refractory to Tumor Necrosis Factor Inhibitor Therapy
Parra-Izquierdo, V; (...); Florez-Sarmiento, C
Meeting Abstract. 10.14309/01.ajg.0000996092.66504.a2. 2023
Worldwide Dissemination of blaKPC Gene by Novel Mobilization Platforms in Pseudomonas aeruginosa: A Systematic Review
Forero-Hurtado D; (...); Escobar-Pérez J
Review. 10.3390/antibiotics12040658. 2023
Campos de estudio
Citar el proyecto
Evaluación del resistoma intestinal de pacientes con espondilo artritis y su relación con microbioma y marcadores de inflamación. 2023-2024.